Oncolytics Biotech Inc ONCY

Roche

[lonc17]

Okay, here's something I missed. 

On the "Pipline" page on the Investor Presentation, Oncolytics is showing that Roche is the partner for their pending and promised P3 in pancreatic cancer. 

https://oncolyticsbiotech.com/pipeline/

Is this a goof up on ONC's part or is it true?

If it is true, then congratulations, I was wrong, it looks like ONC has the necessary funding and expertise in place to run their P3.

On the other hand, if it is simply an indication that ONC "hopes" to run the P3 using Roche's immunotherapy but has no real commitment from them at this time then it is totally bush league and futher evidence (as if we needed any) that MC is an expert at misleading investors.

[venture009]

Collaboration and Partnering are two distinctly different and they define the differences in their summation at the end of the Pipeline segment. 

[venture009]

Collaboration and Partnering are two distinctly different and they define the differences in their summation at the end of the Pipeline segment.@

[lonc17]

Collaboration and Partnering are certainly not distincly different, as shown in the text at the end of the pipeline slide. Oncolytics uses the two words interchangeably, you can see this from simply looiking at the heading and their first sentence!  Throw the text into chatgbt and even one of the most advance AI's will tell you that based on ONC's usage of the terms the differences

[canadafan]

Not sure why you consider the phase 3 Roche trial information as deceptive? The phase 2 trail was set up with Roche as the " Gobblet" blanket of 4 cohorts. Three of which were showed efficacy results @ very early indication. Good news for Panc. As most don't live very long. Moving forward to a phase 3 trial as that combo- therapy makes 100% sense. What that relationship is called

[canadafan]

The original Goblet NR still available to read. Was called a collaboration. Roche supplied product. being their lesd cancer drug Tecentriq. Will the phase 3 be an extension of that agreement? Could very well be. Back then to the funding question. Back to my overview & very important point. There are those who enjoy throwing around words like deception, fraud lies. There is no way on Earth

[lonc17]

Canadafan,  I agree with you about the use of Roche's trademark - ONC must have their approval.  I disagree with you that it is ONC's communication team that is responsible for the slide deck, rather than Matt Coffey. Remember, ONC is a microcap biotech with about a dozen employees. MC has absolutely nothing to due day after day, week after week, except wait for the phone to

[canadafan]

Your suggestion Dr Matt has little to do other than sit & wait for the phone is naive, misinformed, childish & upinsulting to the whole program. should you be following the bouncing ball, majority of Pela trials, while not run directly by Onc, they are " peer reviewed" prior to being published. Dr Matt is involved in majority of the FDA dealings. He afterall holds the patent

[Noteable]

Amen Canadafan

[Noteable]

This post has been removed in accordance with Community Policy